Strata Critical Medical (SRTA) Profit After Tax (2019 - 2026)

Strata Critical Medical (SRTA) has 8 years of Profit After Tax data on file, last reported at $2.4 million in Q1 2026.

• Profit After Tax for Q1 2026 came in at $2.4 million, up 168.77% year-over-year; the trailing twelve-month figure through Mar 2026 was $112.1 million (up 563.17% YoY), and the FY2025 annual result was $41.3 million, up 355.84% from the prior year.
• Profit After Tax slipped to $2.4 million in Q1 2026 per SRTA's latest filing, from $56.0 million in the prior quarter.
• Over five years, Profit After Tax peaked at $57.4 million in Q3 2025 and troughed at -$33.9 million in Q4 2023.
• A 5-year average of -$142062.5 and a median of -$4.0 million in 2024 frame the typical range for Profit After Tax.
• The sharpest annual moves came in 2024 and 2025: Profit After Tax plunged 776.12% in 2024, then jumped 3038.38% in 2025.
• A 5-year view of Profit After Tax shows it stood at -$27.3 million in 2022, then decreased by 24.51% to -$33.9 million in 2023, then surged by 78.11% to -$7.4 million in 2024, then jumped by 854.04% to $56.0 million in 2025, then tumbled by 95.71% to $2.4 million in 2026.
• Business Quant data shows SRTA's Profit After Tax at $2.4 million in Q1 2026, $56.0 million in Q4 2025, and $57.4 million in Q3 2025.